Pancreatic Cancer Research

ResearcherNorth Sichuan Medical UniversityActive in the last 2 years

Linhong Deng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1970-8239; OpenAlex author ID A5100604591. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 6

  1. Responsive nanomedicine strategies achieve pancreatic cancer precise theranostics. Co-author DOI 10.1016/j.bioactmat.2025.08.012↗
  2. Ran drives pancreatic cancer metastasis by activating the osteopontin-PI3K/AKT-androgen receptor signaling cascade. Co-author DOI 10.1016/j.taap.2025.117328↗
  3. [Retracted] Mammalian STE20‑like kinase 1 regulates pancreatic cancer cell survival and migration through Mfn2‑mediated mitophagy. Last author DOI 10.3892/mmr.2024.13294↗
  4. Mammalian STE20‑like kinase 1 regulates pancreatic cancer cell survival and migration through Mfn2‑mediated mitophagy. Last author DOI 10.3892/mmr.2020.11098↗
  5. Ran GTPase protein promotes metastasis and invasion in pancreatic cancer by deregulating the expression of AR and CXCR4. Co-author DOI 10.4161/cbt.29217↗
  6. Ran GTPase protein promotes human pancreatic cancer proliferation by deregulating the expression of Survivin and cell cycle proteins. Co-author DOI 10.1016/j.bbrc.2013.09.079↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yongli Hu · 2 shared papers, 2020–2024 · strength 0.39
  2. Haichuan Su · 1 shared paper, 2025 · strength 0.27
  3. Fangjian Li · 1 shared paper, 2026 · strength 0.25
  4. Yongfu Xiong · 1 shared paper, 2026 · strength 0.25
  5. Xuegang Guo · 2 shared papers, 2013–2014 · strength 0.07
  6. Daiming Fan · 2 shared papers, 2013–2014 · strength 0.07
  7. Kaichun Wu · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.